Is geomagnetic activity a risk factor for sudden unexplained death in epilepsies?
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: To test the hypothesis that sudden unexplained death (SUD) in epilepsy is related to geomagnetic activity.
Background: Prior studies presume that geomagnetic activity (with average amplitudes above 50 nanotesla [nT]) is associated with SUD in epileptic human patients and in epileptic laboratory rats.
Methods: In a retrospective study, 46 epileptic patients with definite SUD were compared with 108 epileptic patients with known cause of death (KCD) who died between 1981 and 1992. A complete postmortem examination was performed in all cases. The time of the day and date of death, as well as two international geomagnetic indices concerning Bartels’ planetary 3-hour signs (Kp) and the mean planetary daily amplitudes (Ap) at time of death, were assessed.
Results: Among 45 SUD individuals, the local time (37.8%) and the universal time of death (35.6%) peaked within the critical period between 3 to 9 am. However, the SUD and KCD group did not substantially differ in regard to the distribution of local or universal time of death (p > 0.2, Fisher test). Neither the Kp signs at death and 2 hours before death nor the Ap values showed considerable differences between the SUD and KCD series (p > 0.2, Mann-Whitney test). Merely 4.3% of SUD patients and 3.7% of KCD patients were associated with Ap indices above 50 nT (p > 0.2, Fisher test).
Conclusion: The results do not support the hypothesis that geomagnetic activity is related to occurrence of sudden unexplained death in epileptic patients.
- Received March 8, 1999.
- Accepted November 1, 1999.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Population-based study of the incidence of sudden unexplained death in epilepsyD. M. Ficker, E. L. So, W. K. Shen et al.Neurology, November 01, 1998 -
Article
Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsyDileep R. Nair, Kenneth D. Laxer, Peter B. Weber et al.Neurology, July 20, 2020 -
Article
Socioeconomic disparities in SUDEP in the USEsma Cihan, Dale C. Hesdorffer, Michael Brandsoy et al.Neurology, April 23, 2020 -
Articles
Sudden unexplained death in children with epilepsyElizabeth J. Donner, Charles R. Smith, O. Carter Snead III et al.Neurology, August 14, 2001